⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABBV News
ABBVIE INC.
Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL)
globenewswire.com
GMAB
ABBV
Chainguard Launches Commercial Builds with Industry Leaders, Setting a New Standard for Verifiable, Zero-Vulnerability Software
prnewswire.com
ESTC
GLBZ
GRAF
TIGR
SNOW
FTNT
HPE
OPEN
CHKP
CAN
PANW
CRWD
ZS
DDOG
MDB
SMCI
AMD
NVDA
INTC
AMZN
GOOG
MSFT
IBM
ORCL
CRM
ADBE
PYPL
NFLX
CMCSA
DIS
VZ
T
KO
PEP
JNJ
PG
XOM
CVX
UNH
JPM
BAC
WFC
C
GS
MS
AMGN
GILD
BMY
PFE
MRK
ABBV
LLY
MDT
ISRG
COST
WMT
HD
MCD
SBUX
NKE
BA
CAT
GE
HON
RTX
LMT
GD
MMC
AXP
V
MA
MSCI
ADP
AMAT
ASML
QCOM
AVGO
TXN
ADSK
CDNS
SNPS
MRVL
GOOGL
Alloy Therapeutics Enters Into Agreement to Advance Novel Antibody Discovery Platform
businesswire.com
ABBV
ALOY
Allergan Aesthetics Redefines Skin Quality Communication with Launch of Skin Quality Index
prnewswire.com
ABBV
Genmab Announces Topline Results for Epcoritamab (DuoBody® CD3xCD20) from Phase 3 EPCORE® DLBCL-1 Trial in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
globenewswire.com
GMAB
ABBV
New York Plastic Surgical Group and Deep Blue Med Spa Named #1 in New York by Allergan Aesthetics for the Second Year in a Row
globenewswire.com
ABBV
Viokace (AbbVie) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
ABBV
Survanta (AbbVie) Market Research Report 2026: Epidemiology, Pipeline Analysis, Trends, Strategies, and Forecasts, 2020-2025, 2025-2030F, 2035F
globenewswire.com
ABBV
Endometriosis Market Expected to Achieve Significant CAGR During the Forecast Period (2026-2036) Driven by Innovative Treatment Options | DelveInsight
prnewswire.com
ABBV
PFE
Pharma Leaders Discuss Managing Revenue Management System Updates at Model N Rainmaker Panel Hosted by RevSavvy
prnewswire.com
GILD
ASND
ABBV